A Possible Case of Venlafaxine-Induced Stevens-Johnson Syndrome
Nicholas Weiss, Lee Jones, John Chamberlain
The Journal of Clinical Psychiatry October 15, 2004 DOI: 10.4088/jcp.v65n1020d (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Case study Case report Peer reviewed |
|---|---|
| Sample size | 1 |
| Population | A person who used peyote |
| Intervention | sleep initiation |
| Topics | Mescaline |
| Keywords | Hallucinogen Psychosis Sleep deprivation Sleep system call Drug-induced adverse reactions Chemotherapy-related skin toxicity |
| Citations | 33 |
| Key findings | Prolonged peyote-triggered psychosis and sleep deprivation were resolved by sleep initiation. |
Abstract
Article AbstractBecause this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.Sir: Psychosis due to sleep deprivation has been frequently reported.1 In hallucinogen use, however, the duration of sleep deprivation is usually limited to a few days, and psychosis is attributed to the direct effects of the hallucinogens on the central nervous system. As a source of hallucinogen, the peyote cactus has been used both as a psychedelic drug and, among many Native Americans in the southwestern United States and Mexico, as a spiritual sacrament. The active ingredient is believed to be mescaline, an alkaloid known to cause visual hallucinations and decreased sleep. These effects subside in a few days, with an average duration of 10 to 12 hours.2 Here, we report a case of prolonged peyote-triggered psychosis and sleep deprivation that was resolved by sleep initiation.
Comparable studies
Other case reports and case series on mescaline, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Parkinsonism after Taking Ecstasy 29-year-old man | 1999 | Case study | n = 1 |
| Methylenedioxyamphetamine. Clinical description of overdose, death, and review of pharmacology A patient with methylenedioxyamphetamine intoxication | 1981 | Case study | n = 1 |
| A New Hallucinogen: 3,4,5-Trimethoxyphenyl-β-Aminopropane | 1955 | Case study | |
| Peyote and mescaline exposures: a 12-year review of a statewide poison center database Patients who used peyote or mescaline and required treatment | 2010 | Case series | |
| A Mescaline Associated Fatality A single deceased individual under the influence of mescaline | 1985 | Case study | n = 1 |